Trials / Completed
CompletedNCT02218138
Learning to BREATHE: A Randomized Controlled Trial to Lower Diabetes Risk in Adolescent Girls
Depression and Insulin Resistance in Adolescents
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 35 (actual)
- Sponsor
- Colorado State University · Academic / Other
- Sex
- Female
- Age
- 12 Years – 17 Years
- Healthy volunteers
- Accepted
Summary
Type 2 diabetes is a chronic disease that puts people at risk for major health problems like heart disease. Type 2 diabetes is the most common type of diabetes in adults. However, there has been a concerning rise in type 2 diabetes among teenagers. Diabetes develops through poor insulin sensitivity, meaning that insulin - an important chemical the body makes to keep blood sugar normal - isn't working properly. Type 2 diabetes can be prevented by improving insulin sensitivity. Stress is related to insulin sensitivity. Individuals who feel stressed have worse insulin sensitivity than individuals who do not feel stressed. In adults, decreasing stress leads to improvements in insulin sensitivity, but this hasn't been tested in teenagers. The purpose of this study is to find out if taking part in a brief group program to decrease stress will improve insulin sensitivity and lower diabetes risk in teenage girls.
Detailed description
After a screening to determine eligibility, girls are randomly assigned to take part in one of two 6-week group programs: 1) Learning to BREATHE - a mindfulness-based program, or 2) Colorado Blues - a cognitive-behavioral program. After the group, girls return for three follow-up visits over the course of a year. The main outcomes are depressive symptoms and insulin resistance. We also are assessing stress, eating behavior, fitness, and mindfulness.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Learning 2 BREATHE | Mindfulness-based group program |
| BEHAVIORAL | Colorado Blues | Colorado Blues, Cognitive-behavioral depression prevention group |
Timeline
- Start date
- 2013-01-01
- Primary completion
- 2016-08-01
- Completion
- 2016-08-01
- First posted
- 2014-08-15
- Last updated
- 2020-03-12
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02218138. Inclusion in this directory is not an endorsement.